Personalized at-home neurofeedback compared with long-acting methylphenidate in an european non-inferiority randomized trial in children with ADHD

26Citations
Citations of this article
214Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Neurofeedback (NF) has gained increasing interest among non-pharmacological treatments for Attention Deficit Hyperactivity Disorder (ADHD). NF training aims to enhance self-regulation of brain activities. The goal of the NEWROFEED study is to assess the efficacy of a new personalized NF training device, using two different protocols according to each child's electroencephalographic pattern, and designed for use at home. This study is a non-inferiority trial comparing NF to methylphenidate. Methods: The study is a prospective, multicentre, randomized, reference drug-controlled trial. One hundred seventy-nine children with ADHD, aged 7 to 13 years will be recruited in 13 clinical centres from 5 European countries. Subjects will be randomized to two groups: NF group (Neurofeedback Training Group) and MPH group (Methylphenidate group). Outcome measures include clinicians, parents and teachers' assessments, attention measures and quantitative EEG (qEEG). Patients undergo eight visits over a three-month period: pre-inclusion visit, inclusion visit, 4 "discovery" (NF group) or titration visits (MPH group), an intermediate and a final visit. Patients will be randomized to either the MPH or NF group. Children in the NF group will undergo either an SMR or a Theta/Beta training protocol according to their baselineTheta/Beta Ratio obtained from the qEEG. Discussion: This is the first non-inferiority study between a personalized NF device and pharmacological treatment. Innovative aspects of Mensia Koala™ include the personalization of the training protocol according to initial qEEG characteristics (SMR or Theta/Beta training protocols) and an improved accessibility of NF due to the opportunity to train at home with monitoring by the clinician through a dedicated web portal. Trial registration: NCT02778360. Date registration (retrospectively registered): 5-12-2016. Registered May 19, 2016

References Powered by Scopus

The strengths and difficulties questionnaire: A research note

11684Citations
N/AReaders
Get full text

Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): Initial reliability and validity data

8516Citations
N/AReaders
Get full text

EEG alpha and theta oscillations reflect cognitive and memory performance: A review and analysis

5514Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Neurotherapeutics for attention deficit/hyperactivity disorder (ADHD): A review

60Citations
N/AReaders
Get full text

The potential for emerging technologies to support self-regulation in children with ADHD: A literature review

55Citations
N/AReaders
Get full text

PhyDAA: Physiological Dataset Assessing Attention

33Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Bioulac, S., Purper-Ouakil, D., Ros, T., Blasco-Fontecilla, H., Prats, M., Mayaud, L., & Brandeis, D. (2019). Personalized at-home neurofeedback compared with long-acting methylphenidate in an european non-inferiority randomized trial in children with ADHD. BMC Psychiatry, 19(1). https://doi.org/10.1186/s12888-019-2218-0

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 53

72%

Researcher 9

12%

Professor / Associate Prof. 8

11%

Lecturer / Post doc 4

5%

Readers' Discipline

Tooltip

Psychology 28

41%

Medicine and Dentistry 16

23%

Neuroscience 13

19%

Nursing and Health Professions 12

17%

Article Metrics

Tooltip
Social Media
Shares, Likes & Comments: 8

Save time finding and organizing research with Mendeley

Sign up for free